Document Type
Article
Publication Date
11-1-2020
Abstract
COVID-19 infection causes considerable morbidity and mortality, especially to those who are aged, have impaired renal function and are obese. We propose to examine the potential utility of oral activated charcoal with the hypothesis that such treatment would lower absorption of microbiome derived toxins and ameliorate systemic oxidant stress and inflammation.
Recommended Citation
Khitan ZJ, Khawaja I, Mufson MA, Sanabria JR, Abraham NG, Peterson SJ, Sundaram U, Shapiro JI. Can charcoal improve outcomes in COVID-19 infections?. Medical Hypotheses. 2020 Nov 1;144:110176.
Comments
The version of record is available from the publisher at https://doi.org/10.1016/j.mehy.2020.110176.
Copyright © 2020 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).